Electrical stimulation is a therapeutic treatment to treat muscle spasms and pain. It prevents atrophy and builds strength in patients with injuries. It is helpful to keep muscles active, especially after a spinal cord injury or stroke. Electrical muscle stimulation can be used to strengthen weak pelvic floor muscles. Stimulating activity can be achieved by passive contraction of the pelvic floor muscles through the transmission of low grade electrical impulses to the nerves that supply impulse to the bladder and other sections in the pelvic area. The small electrical impulses are delivered to the pelvic structures through an internal vaginal method or anal electrode method. Posterior tibial nerve stimulation (PTNS) is done by inserting a small electrode through skin of lower legs. The electrode can be connected through pulse generator. Similarly, sacral nerve stimulation (SNS) is done using a pacemaker like stimulator above the skin which plays an important role in functioning of the bladder. However, new developments in medical devices allow imaging at the cellular and molecular level, paving the way for earlier diagnosis and treatment by pelvic floor stimulation.
High prevalence of diseases such as urinary infection, neurological diseases, rising patient awareness, growing research and development initiatives, and increasing demand for electric stimulation devices such as electrodes and pacemakers are the major factors driving the global pelvic floor electrical stimulation device market. According to the Centers for Medicare and Medicaid Services, 17 million adults in the U.S. suffer from urinary incontinence, where women are twice affected as compared to men. Nearly 35% of female Medicare beneficiaries and 25% of male beneficiaries are estimated to suffer from urinary incontinence. Cost of reagents and sensitivity toward electrical impulses from the devices used during treatment are expected to hamper the pelvic floor electrical stimulation device market from 2016 to 2024.
The global pelvic floor electrical stimulation device market has been segmented by device type, treatment, end-user, and geography. In terms of device type, the pelvic floor electrical stimulation market is classified into non-implantable electrical stimulator device and implantable electrical stimulator device. Based on treatment type, the market is classified into pelvic floor muscle training (PFMT), intravaginal neuromuscular electrical stimulation (NMES), and transcutaneous tibial nerve stimulation (TTNS). In terms of end-user, the pelvic floor electrical stimulation device market is classified into hospitals and ambulatory surgical units.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17438
The non-implantable device type segment is projected to witness strong growth driven by increase in urinary incontinence among the population, rising number of elderly women, and obesity. The Journal of Wound Ostomy and Continence Nursing 2016 has conducted a study to evaluate the effect of intravaginal neuromuscular electrical stimulation (NMES) and transcutaneous tibial nerve stimulation (TTNS) on lower urinary tract symptoms (LUTS) in women with multiple sclerosis disease in order to compare the efficacy of the approaches.
Geographically, the global pelvic floor electrical stimulation device market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global pelvic floor electrical stimulation device market due to increasing number of elderly women, rising obesity, and urinary infection rates. Early-phase diagnosis and treatment of disease is driving the medical biotechnology market, which in turn is expected to propel the pelvic floor electrical stimulation device market in North America. Europe is the second largest market for pelvic floor electrical stimulation devices due to favorable government policies regarding improvement of health standards for women and awareness programs by NHS and other health institutions. The market in Asia Pacific is expected to grow at a higher rate due to rising population, changing lifestyle, aging population, and increasing per capita expenditure. In addition, economic growth has led to improvement in health care infrastructure in developing countries such as India, China, and southeast Asia. These factors collectively support the growth of the pelvic floor electrical stimulation device market in Asia Pacific.
Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=17438
Major players operating in the global pelvic floor electrical stimulation device market include Boston Scientific, Coloplast A/S, C. R. Bard, Inc., and Ethicon, Inc. (Johnson & Johnson).
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453